Voorbeelden van het gebruik van Data on safety in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Data on safety and tolerance will be collected and evaluated.
Lansoprazole is not recommended for use in children due to insufficient data on safety and efficacy.
Data on safety of Spectrila in infants< 1 year of age is limited.
Therefore, its use in paediatric patients is not recommended due to a lack of data on safety and efficacy.
There are limited data on safety in patients with prior history of stroke
Mensen vertalen ook
Pradaxa is not recommended for use in patients below 18 years due to lack of data on safety and efficacy.
There is limited data on safety and efficacy of dalbavancin when administered for more than two doses one week apart.
Nplate is not recommended for use in children below age 18 due to insufficient data on safety or efficacy.
CELSENTRI is not recommended for use in children due to lack of data on safety, efficacy and pharmacokinetics see section 5.2.
due to lack of data on safety and efficacy.
adolescents due to a lack of data on safety and efficacy see section 4.4.
ADARTREL is not recommended for use in children below 18 years due to a lack of data on safety and efficacy.
Norvir is not recommended in children below 2 years of age due to lack of data on safety and efficacy.
adolescents below 18 years due to insufficient data on safety and efficacy.
Use in children Alendronate HEXAL is not recommended for use in children due to a lack of data on safety and efficacy.
Aerinaze should not be used in children below the age of 12 years due to a lack of data on safety and efficacy see section 5.1.
adolescents due to insufficient data on safety and efficacy.
adolescents due to a lack of data on safety and efficacy see section 5.3.
Ketek is not recommended for use in children below 12 years of age due to lack of data on safety and efficacy see section 5.2.
adolescents below 18 years due to a lack of data on safety and efficacy.
Paediatric use Herceptin is not recommended for use in children below 18 due to insufficient data on safety and efficacy.
adolescents below 18 years due to a lack of data on safety and efficacy.
Revatio solution for injection is not recommended for use in children below 18 years due to insufficient data on safety and efficacy.
Children and adolescents Bondronat is not recommended for patients below age 18 years due to insufficient data on safety and efficacy.
Revolade is not recommended for use in children under the age of one year with chronic ITP due to insufficient data on safety and efficacy.
adolescents due to a lack of data on safety and efficacy.
STELARA is not recommended for use in children below age 18 due to a lack of data on safety and efficacy.
adolescents due to insufficient data on safety and efficacy see section 5.2.
adolescents due to a lack of data on safety and efficacy in these sub-populations.
adolescents below 18 years due to a lack of data on safety and efficacy.